AI assistant
Sai Life Sciences Limited — Share Issue/Capital Change 2025
Jun 27, 2025
61699_rns_2025-06-27_c2d25f67-774b-4330-bffc-a7d513ea2524.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
==> picture [147 x 34] intentionally omitted <==
27 June 2025
| To BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400001 Scrip Code:544306 |
To National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Symbol:SaiLife |
|---|---|
Sub: Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Allotment of equity shares under Management ESOP Plan 2018 (“MESOP 2018”).
Dear Sir/ Madam,
Pursuant to Regulation 30 read with Schedule III to the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015 (“Listing Regulations”), we wish to inform you that the Board of Directors of the Company has approved and allotted 40,403 fully paid-up equity shares of Re.1/ each upon exercise of options granted under MESOP 2018, vide circular resolution dated 26[th] June, 2025.
The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are enclosed herewith as Annexure-A .
Further, the details required as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024 are enclosed as Annexure-B .
We request you to take note of the same and oblige.
Thanking you.
For Sai Life Sciences Limited
RUNA Digitally signed by RUNA KARAN KARAN Date: 2025.06.27 10:18:34 +05'30' ____
Runa Karan
Company Secretary & Compliance Officer Membership No.: A13721
Encl: As above
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office
Registered office
Plot No. DS-7, IKP Knowledge Park, Turkapally (V), Shameerpet Mandal, Medchal-Malkajgiri (Dist), Hyderabad -500078, Telangana, India.
Contact us T: +91 40 6815 6000, F: +91 40 6815 6199 E: [email protected] W: www.sailife.com
L4-01 & 02, SLN Terminus, Survey #133, Gachibowli Miyapur Road, Gachibowli, Hyderabad – 500032, Telangana, India.
==> picture [147 x 34] intentionally omitted <==
Annexure - A
Details under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
| 1 | Company name and address of Registered Office: Sai Life Sciences Limited Plot No. DS-7, IKP Knowledge Park, Turkapally (V) Shameerpet Mandal, Medchal-Malkajgiri Dist, Rangareddi, Hyderabad, Telangana, India, 500078 |
Company name and address of Registered Office: Sai Life Sciences Limited Plot No. DS-7, IKP Knowledge Park, Turkapally (V) Shameerpet Mandal, Medchal-Malkajgiri Dist, Rangareddi, Hyderabad, Telangana, India, 500078 |
|
|---|---|---|---|
| 2 | Name of the Stock Exchanges on which the company’s shares are listed: BSE Limited (“BSE”) National Stock Exchange of India Limited (“NSE”) |
||
| 3 | Filing date of the statement referred in regulation 10(b) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 with Stock Exchange: 08 January 2025 (BSE & NSE) |
||
| 4 | Filing Number, if any: | 220874 46557 |
|
| BSE | 220874 | ||
| NSE | 46557 | ||
| 5 | Title of the Scheme pursuant to which shares are issued, if any: Management ESOP Plan 2018 |
||
| 6 | Kind of security to be listed:Equity Shares | ||
| 7 | Par value of the shares:Re 1/- per share | ||
| 8 | Date of issue of shares:26 June 2025 (Allotment on exercise of options) | ||
| 9 | Number of shares issued:40403 | ||
| 10 | Share Certificate No., if applicable:Not Applicable. Shares are issued in Dematerialized form | ||
| 11 | Distinctive number of the share, if applicable:208504900 to 208545302 (both inclusive) | ||
| 12 | ISIN Number of the shares if issued in Demat:INE570L01029 | ||
| 13 | Exercise price per share:Rs 23.30/- per share for allotment of 40136 shares (MESOP 2018) Exercise price per share:Rs 127.30/- per share for allotment of 267 shares (MESOP 2018) |
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office
Registered office
Plot No. DS-7, IKP Knowledge Park, Turkapally (V), Shameerpet Mandal, Medchal-Malkajgiri (Dist), Hyderabad -500078, Telangana, India.
Contact us T: +91 40 6815 6000, F: +91 40 6815 6199 E: [email protected] W: www.sailife.com
L4-01 & 02, SLN Terminus, Survey #133, Gachibowli Miyapur Road, Gachibowli, Hyderabad – 500032, Telangana, India.
==> picture [147 x 34] intentionally omitted <==
| 14 | Premium per share:Re. 22.30/- Per Share (MESOP 2018) Premium per share:Re. 126.30/- Per Share (MESOP 2018) |
|---|---|
| 15 | Total Issued shares after this issue:208545302 |
| 16 | Total Issued share capital after this issue:208545302 |
| 17 | Details of any lock-in on the shares:NA |
| 18 | Date of expiry of lock-in:NA |
| 19 | Whether shares identical in all respects to existing shares if not, when will they become identical: NA |
| 20 | Details of listing fees, if payable:NA |
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. Telangana, India.
Contact us T: +91 40 6815 6000, F: +91 40 6815 6199 E: [email protected] W: www.sailife.com
==> picture [147 x 34] intentionally omitted <==
Annexure- B
Details required under Regulation 30 read with Schedule III of the Listing Regulations and as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11 November 2024.
| Sl. No. |
Disclosures | Particulars – MESOP 2018 |
|---|---|---|
| a) | brief details of options granted | The present instance is for allotment of shares upon exercise of 40403 options under Management ESOP Plan 2018 |
| b) | Whether the scheme is in terms of SEBI (SBEB) Regulations, 2021 (if applicable) |
Yes |
| c) | total number of shares covered by these options |
The present disclosure is in respect of allotment of 40403 shares made on 26 June 2025. |
| d) | pricing formula | The price payable by an Employee on Exercise is determined by the Nomination and Remuneration Committee and in conformity with applicable accounting Standards, the SEBI SBEB & SE Regulations as applicable from time to time. |
| e) | options vested | NA as the intimation is towards allotment of shares pursuant to exercise of ESOPs |
| f) | time within which option may be exercised |
NA as the intimation is towards allotment of shares pursuant to exercise of ESOPs |
| g) | options exercised | The present instance is for allotment of shares upon exercise of 40403 options under Management ESOP Plan 2018. |
| h) | money realized by exercise of options |
INR 969157.90/- |
| i) | the total number of shares arising as a result of exercise of option |
40403 |
| j) | options lapsed | NA as the intimation is towards allotment of shares pursuant to exercise of ESOPs |
| k) | variation of terms of options | NA |
| l) | brief details of significant terms | The objective of ESOP 2018 is to provide an incentive to attract, retain and reward employees and contribute to the growth of the Company. The ESOP 2018 has a maximum vesting period of 5 years with multiple options of vesting as per clause 5 of the ESOP 2018. The exercise period is till the employee is in the service of the company as per clause 7 of ESOP 2018. |
| m) | subsequent changes or cancellation or exercise of such options |
NA |
| n) | diluted earnings per share pursuant to issue of equity shares on exercise of options |
NA |
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office
Registered office
L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. Telangana, India.
Contact us
T: +91 40 6815 6000, F: +91 40 6815 6199 E: [email protected] W: www.sailife.com